Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.488 EUR | +4.27% | +3.83% | +9.42% |
2023 | BioXXmed AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Sales 2021 | 44.63K 47.88K | Sales 2022 | 12.23K 13.13K | Capitalization | 5.91M 6.34M |
---|---|---|---|---|---|
Net income 2021 | -4M -4.29M | Net income 2022 | - 0 | EV / Sales 2021 | 429 x |
Net Debt 2021 | 121K 130K | Net cash position 2022 | 1.84M 1.97M | EV / Sales 2022 | 333 x |
P/E ratio 2021 |
-4.68
x | P/E ratio 2022 |
-7.12
x | Employees | 1 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 40.86% |
1 day | +6.84% | ||
1 week | +6.38% | ||
Current month | +33.69% | ||
1 month | +33.69% | ||
6 months | -57.63% | ||
Current year | +12.11% |
Managers | Title | Age | Since |
---|---|---|---|
Bruno Rosen
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ralph Bieneck
BRD | Director/Board Member | 56 | - |
Arne Segler
CHM | Chairman | - | - |
Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.488 | +4.27% | 1 027 |
24-04-25 | 0.468 | 0.00% | 239 |
24-04-24 | 0.468 | -0.43% | 239 |
24-04-23 | 0.47 | +0.86% | 239 |
24-04-22 | 0.466 | -0.85% | 750 |
Delayed Quote Xetra, April 26, 2024 at 06:02 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+12.11% | 2.58M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.64% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- T5O Stock